Newsbenzinga
TG Therapeutics Initiates Phase 2 Clinical Trial Evaluating BRIUMVI As Maintenance Therapy Following Induction With Efgartigimod In Adult Patients With MG
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…